Bioneur provides strategic and operational support to bio-pharmaceutical companies that are eager to meet the unmet medical needs of patients who suffer from a rare disease and live in countries outside of the US and Europe.

To facilitate immediate access to these markets Bioneur can introduce you to several very carefully selected pharmaceutical companies/distributors that have hands-on experience with named patient sales, pre-commercial activities, regulatory, pricing, reimbursement, sales, marketing, distribution and that has an excellent relationship with the local rare disease communities the Asia Pacific region, Africa and Latin America.

Conversely Bioneur provides strategic support to biopharmaceutical companies located outside of the US and Europe that have interest to 1) file for regulatory approval and 2) to partner with local specialized companies/distributors, in preparation for the introduction of their product(s) in the US and Europe.